Atara Biotherapeutics Announces $36M Registered Direct Offering Of 758,900 Shares At $8.25/Share
Portfolio Pulse from Benzinga Newsdesk
Atara Biotherapeutics has announced a registered direct offering of 758,900 shares at $8.25 per share, raising $36 million.
September 03, 2024 | 8:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Atara Biotherapeutics is conducting a registered direct offering of 758,900 shares at $8.25 per share, raising $36 million.
The direct offering increases the number of shares available, which can dilute existing shareholders' value and potentially lead to a short-term decrease in stock price. The offering price of $8.25 may also act as a short-term price ceiling.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100